Results 71 to 80 of about 8,099 (196)

Imaging assessment after SBRT for hepatocellular carcinoma

open access: yes, 2020
The use of stereotactic body radiotherapy (SBRT) in hepatocellular carcinoma (HCC) has increased over the past few decades. Thus, accurate evaluation of post-SBRT treatment response is essential to avoid over-treatment of responders as well as missing ...
Cook, Gary J. R.   +3 more
core  

PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRT [PDF]

open access: yes
PACE-NODES is a phase III randomised controlled trial for patients with high risk localised prostate cancer, planned for radical radiotherapy with at least 12 months of androgen deprivation therapy, and suitable for stereotactic body radiotherapy (SBRT).
Cafferty, Fay H.   +20 more
core   +1 more source

Top 5 Advances in the Last 50 Years: Malignant Gastric and Esophageal Surgery

open access: yes
World Journal of Surgery, EarlyView.
Luís Santos Castro, Lorenzo Ferri
wiley   +1 more source

A dosimetric analysis of a rotating gamma ray system and volumetric modulated arc therapy in retrospective replanning for primary liver cancer

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 6, June 2026.
Abstract Background This study is a retrospective replanning study. For primary liver cancer, radiotherapy is vital for inoperable patients; however, dosimetric data comparing the rotating gamma ray system (RGS) and volumetric modulated arc therapy (VMAT) remains scarce, complicating clinical technique selection. Notably, RGS refers to a body gamma ray
Jiarui Zhang   +8 more
wiley   +1 more source

Lung SBRT through Radiobiology

open access: yes, 2020
Purpose: Stereotactic body radiation therapy (SBRT) has emerged as a standard treatment modality for medically inoperable early-stage lung cancer patients.
Aime M Gloi
core  

Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases:An International Survey of >1000 Radiation Oncologists

open access: yes, 2017
PURPOSE: Stereotactic body radiotherapy (SBRT) is often used to treat patients with oligometastases (OM). Yet, patterns of SBRT practice for OM are unknown.
Lewis, Stephen L   +17 more
core   +1 more source

Interactions of Antibody Drug Conjugate Anti‐Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy

open access: yesAdvanced Science, Volume 13, Issue 35, 24 June 2026.
Antibody drug conjugates deliver their cytotoxic anti‐tubulin or topoisomerase I inhibitor payloads to tumors through cancer cell receptor targeting. The released drug payloads induce cellular changes that interact with radiotherapy resulting in radiosensitization that improves cancer cell kill and stimulates anti‐tumor immune responses.
Jacqueline Lesperance   +17 more
wiley   +1 more source

Stereotactic body radiation therapy (SBRT) in the management of non-small-cell lung cancer: Clinical impact and patient perspectives

open access: yes, 2018
Elysia K Donovan,1,2 Anand Swaminath1,2 1Department of Oncology, McMaster University, Hamilton, ON, Canada; 2Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada Abstract: Stereotactic body radiation therapy (SBRT) has emerged as a
Donovan EK, Swaminath A
core  

Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy

open access: yesFrontiers in Oncology, 2020
Background: To investigate the role of stereotactic body RT (SBRT) in decreased total peripheral lymphocyte count (TLC) in patients with early-stage lung cancer and to explore possible risk factors for RT-induced lymphopenia.Materials and Methods: We ...
Qianqian Zhao   +4 more
doaj   +1 more source

Selenium‐Based Nanoplatforms: An Emerging Theranostic Paradigm for Gynecological Cancers

open access: yesAdvanced Science, Volume 13, Issue 33, 15 June 2026.
This reivew summarizes Selenium as a multifunctional anticancer regulator in gynecological cancers. It reduces tumor risk, enhances therapeutic efficacy, and reduces treatment toxicity. Selenium also overcomes chemoraditherapy resistance, improving overall treatment outcomes. ABSTRACT Gynecological cancers present significant therapeutic challenges due
Hejing Liu   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy